 HOUSTON, Nov. 05, 2020 GLOBE NEWSWIRE -- Aravive, Inc. Nasdaq: ARAV, a clinical-stage oncology company developing transformative therapeutics, today announced recent corporate updates and financial results for the third quarter ended September 30, 2020. 